BAY 77-1931 Long-term Extension From Phase II Study

Status:
Completed

Trial end date:
2008-05-01

Target enrollment:

Participant gender:

A long-term study of BAY77-1931 (lanthanum carbonate) for hyperphosphatemia in patients undergoing hemodialysis

Phase 2

Bayer